Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kathryn Romano currently holds 10,000 shares of Krystal Biotech, Inc. (KRYS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kathryn Romano has been a net seller of KRYS stock. They have purchased $0 and sold $5.8M worth of shares.
Kathryn Romano's most recent insider trade was on Jan 22, 2024, when they sold 2,500 shares at $0.00 per share.
Kathryn Romano serves as Executive at Krystal Biotech, Inc. (KRYS). They have executed 23 insider transactions totaling $5.8M over their tenure at the company.
Kathryn Romano holds the position of Executive at Krystal Biotech, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Kathryn Romano has shown a selling trading pattern, with $0 in total purchases and $5.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kathryn Romano was on May 22, 2023, when they sold $1.4M worth of KRYS shares. This transaction involved 12,500 shares at $110.00 per share.
Kathryn Romano currently owns 10,000 shares of Krystal Biotech, Inc. (KRYS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kathryn Romano's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kathryn Romano has 23 Form 4 filings on record as an insider at Krystal Biotech, Inc..
Set alerts for Kathryn Romano and 40,000+ other insiders.